Adaptive Phage Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.aphage.com
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT05269134
- Locations
- 🇺🇸
University of California San Diego Medical Center, San Diego, California, United States
🇺🇸Hartford Health Care Bone & Joint Insitute, Hartford, Connecticut, United States
🇺🇸Snake River Research, Idaho Falls, Idaho, United States
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
Phase 1
Withdrawn
- Conditions
- Bacterial InfectionsProsthetic Joint Infection
- Interventions
- Biological: Phage Therapy
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT05269121
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
Phase 2
Recruiting
- Conditions
- OsteomyelitisDiabetic Foot Osteomyelitis
- Interventions
- Biological: Phage TherapyOther: Placebo
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Target Recruit Count
- 126
- Registration Number
- NCT05177107
- Locations
- 🇺🇸
Compass Medical Research, Tucson, Arizona, United States
🇺🇸Southern Arizona VA Health Care System, Tucson, Arizona, United States
🇺🇸Central Arkansas Veteran's Healthcare System, Little Rock, Arkansas, United States
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
Phase 1
Withdrawn
- Conditions
- Prosthetic Joint Infection
- Interventions
- Biological: Phage TherapyProcedure: Two-Stage Exchange Arthroplasty
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT04787250
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
- Conditions
- Covid19BacteremiaSepticemiaAcinetobacter Baumannii InfectionPseudomonas Aeruginosa InfectionStaph Aureus Infection
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT04636554
Bacteriophage Therapy in Patients With Urinary Tract Infections
Phase 1
Terminated
- Conditions
- Urinary Tract Infection Bacterial
- Interventions
- Biological: Bacteriophage Therapy
- First Posted Date
- 2020-02-27
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04287478
- Locations
- 🇺🇸
Universal Axon Clinical Research, Doral, Florida, United States
🇺🇸AMPM Research Clinic, Miami Gardens, Florida, United States
🇺🇸AdMed Research, Miami, Florida, United States